Trial
NCT04329195
ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Groupe Hospitalier Pitie-Salpetriere
Condition
History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection
Intervention
1: discontinuation of RAS blocker therapy
Why stopped
insufficient recrutment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-09